---
figid: PMC6523967__cells-08-00321-g001
figtitle: Cyclin D1–CDK4/6–Rb pathway in breast cancer
organisms:
- NA
pmcid: PMC6523967
filename: cells-08-00321-g001.jpg
figlink: /pmc/articles/PMC6523967/figure/cells-08-00321-f001/
number: F1
caption: Cyclin D1–CDK4/6–Rb pathway in breast cancer. The molecular pathway and the
  major interconnected molecules are indicated. The inhibitory strategies that are
  most feasible in combination with CDK4/6 inhibition are indicated.
papertitle: Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer.
reftext: Navid Sobhani, et al. Cells. 2019 Apr;8(4):321.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9538072
figid_alias: PMC6523967__F1
figtype: Figure
organisms_ner:
- Danio rerio
- Homo sapiens
redirect_from: /figures/PMC6523967__F1
ndex: 7a5e1136-deea-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6523967__cells-08-00321-g001.html
  '@type': Dataset
  description: Cyclin D1–CDK4/6–Rb pathway in breast cancer. The molecular pathway
    and the major interconnected molecules are indicated. The inhibitory strategies
    that are most feasible in combination with CDK4/6 inhibition are indicated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ctnnb1
  - cdk4
  - stat1b
  - stat4
  - ar
  - nsg2
  - cdkn2a/b
  - tsc2
  - mtor
  - ccnd1
  - cdk6
  - cdkn1a
  - tp53
  - cdk2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - NFKB1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CDK4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - AR
  - CDKN2A
  - CDKN2D
  - F9
  - REG1A
  - IL23A
  - H3P13
  - CDKN2B
  - MRPL28
  - SUB1
  - NXT1
  - H3P9
  - CDKN2C
  - UBE2I
  - MAFK
  - EEF1E1
  - ZNF197
  - ATRAID
  - LAMTOR1
  - TPPP2
  - H3P12
  - H3P10
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - MTOR
  - CCND1
  - CDK6
  - RPTOR
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - TP53
  - TP63
  - TP73
  - CDKN1C
  - CORO1A
  - H3P47
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - CDK2
  - MPEG1
  - CCNE1
  - CCNE2
  - Al
  - letrozole
  - anastrazole
  - exemestane
  - tamoxifen
  - fulvestrant
  - buparlisib
  - everolimus
  - Cancer
---
